Social media

Biosimilars are positively impacting healthcare in APAC — but awareness and trust remain critical hurdles. ICON explores how strategic education and engagement can unlock biosimilar adoption across Asia-Pacific, from em...

More than 100 million people in the US have some form of liver disease. On November 7-11, meet the ICON team at AASLD, booth \#1041 to learn how we apply flexible partnership and delivery models, supported by robust to...

From a small-town GP to Site Head at ICON Bulgaria, Dimitar Karzhin’s story is one of purpose, growth, and community. Since joining ICON in 2011, Dimitar has seen our Bulgaria operations expand from a remote team of jus...

From a small-town GP to Site Head at ICON Bulgaria, Dimitar Karzhin, MD's story is one of purpose, growth, and community. Since joining ICON in 2011, Dimitar has seen our Bulgaria operations expand from a remote team of...

R, an open-source programming language for statistical computing, is transforming the role of clinical programmers. It enables reproducible research, supports cross team collaboration, and strengthens regulatory complian...

R, an open-source programming language for statistical computing, is transforming the role of clinical programmers. It enables reproducible research, supports cross team collaboration, and strengthens regulatory complian...

Join us at ACoP 2025 for two in-person workshops on October 17th, designed to help you build confidence and gain practical tools for delivering impactful NONMEM presentations. Workshop 1 : New and advanced features of N...

Join us at ACoP 2025 for two in-person workshops on October 17th, designed to help you build confidence and gain practical tools for delivering impactful NONMEM presentations. Workshop 1 : New and advanced features of N...

Pediatric clinical trials have different processes, risks and challenges than adult trials. Identifying those differences is critical but can be difficult, especially if resources are limited. Join ICON’s Heather Peterso...

Clinical development processes for pediatric trials differ from adult trials. Register for our webinar to learn about regulatory strategies and tools needed to ensure pediatric access to medical treatment and an interact...

Mental health conditions are now the second leading cause of long-term disability globally and the third leading cause of death for young people aged 15-29 years. ICON is committed to raising awareness and generating cha...

As awareness of mental health disorders grows, the demand for effective, tech-driven solutions is rising. Our whitepaper explores how SaMD is shaping the future of treatment - offering strategies for successful clinical ...